Mangalam Drugs and Organics Ltd Net Profit is INR 2.15 crores in Q4 FY 2020-2021

Mangalam Drugs and Organics Ltd Q3 FY20-21 Quarter Result { “@context”: “https://schema.org”, “@type”: “NewsArticle”, “Stock”: Mangalam Drugs and Organics Ltd, “Quarter Result”: “December 2020”, “Sales”: 90.79 cr, “Net Profit”: 2.15 cr }

Mangalam Drugs and Organics Ltd Net Profit is INR 2.15 crores in Quarter 4, January – March of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Mangalam Drugs and Organics Ltd Quarter Net Profit is Down by -57 % from Last Year Quarter and Net Profit of INR 2.15 crores is reported in Quarter 4, January – March of Financial Year 2020-2021. Last Year Quarter 4, January – March of Financial Year 2019-2020 Net Profit was INR 5.05 crores.

Quarterly Net Sales Year-on-Year

Mangalam Drugs and Organics Ltd Quarter Sale is up 3 % from Last Quarter. Sales of 90.79 is reported in Quarter 4, January – March of Financial Year 2020-2021. In Last Year Quarter 4, January – March of Financial Year 2019-2020 Sale was 88.09

Annual Sales & Net Earning

Mangalam Drugs and Organics Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 282.33 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 8.25 crores.


Mangalam Drugs and Organics Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs & Formln
AboutMangalam Drugs and Organics Limited is an India-based company, which is engaged in the manufacture of drugs, medicines and allied products.
Latest Qaurter EPS1.3583343891211621

Mangalam Drugs and Organics Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Mangalam Drugs and Organics Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *